Cat. No.: X24-08-YM065
Topoisomerase inhibitor, Karenitecin, Purity ≥98%
Synonym: 203923-89-1; Cositecan; BNP 1350; BNP-1350; BNP1350; (19S)-19-Ethyl-19-hydroxy-10-(2-trimethylsilylethyl)-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
- CAS Number: 203923-89-1
- Compound CID: 148202
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Properties
Description
Karenitecin is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting topoisomerase.
Molecular Formula
C25H28N2O4Si
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Karenitecin is a DNA damage inhibitor that can be used for its ability to disrupt DNA replication and induce cancer cell death.
Storage
Store at -20ºC, and keep desiccated.
Related Products
- Topoisomerase inhibitor, ABT-492, Purity ≥98%
- Topoisomerase inhibitor, Amonafide, Purity ≥98%
- Topoisomerase inhibitor, Camptothecin, Purity ≥98%
- Topoisomerase inhibitor, Gatifloxacin, Purity ≥98%
- Topoisomerase inhibitor, Idarubicin HCl, Purity ≥98%
- Topoisomerase inhibitor, Irinotecan, Purity ≥98%
